Clavulanic acid
Clavulanic acid is a β-lactam drug that functions as a mechanism-based β-lactamase inhibitor. While not effective by itself as an antibiotic, when combined with penicillin-group antibiotics, it can overcome antibiotic resistance in bacteria that secrete β-lactamase, which otherwise inactivates most penicillins.
Clinical data | |
---|---|
Pronunciation | /ˌklævjʊˈlænɪk/ |
AHFS/Drugs.com | International Drug Names |
Pregnancy category |
|
Routes of administration | Oral, IV |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | "Well absorbed" |
Metabolism | Hepatic (extensive) |
Elimination half-life | 1 hour |
Excretion | Renal (30–40%) |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.055.500 |
Chemical and physical data | |
Formula | C8H9NO5 |
Molar mass | 199.162 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
| |
(verify) |
In its most common preparations, potassium clavulanate (clavulanic acid as a salt of potassium) is combined with:
- amoxicillin (co-amoxiclav, trade names Augmentin, Clavulin, Tyclav, Clavaseptin (veterinary), Clavamox (veterinary), Synulox (veterinary), and others)
- ticarcillin (co-ticarclav, trade name Timentin)
Clavulanic acid was patented in 1974.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.